Assessment of Autonomic
arkinson's disease (PD) was first described by British physician James Parkinson as "shaking palsy" in 1817. Cardinal symptoms of the disease are resting tremor, reduction in voluntary and associated movements, increase in tonus as rigidity and postural instability. In addition to these symptoms, autonomous symptoms and signs due to degeneration of spinal autonomous neurons and side effects of medications used to treat the disease particularly in advanced stages of disease (1, 2) . Prolongation of QT interval due to autonomic dysfunction was observed in Parkinson patients in the literature and sudden deaths due to this finding were reported (1) .
In this study, we aimed to investigate QT interval changes and relationship of this parameter with gender, disease duration and treatment in order to evaluate autonomic dysfunction in Parkinson patients.
METHODS
Twenty Parkinson patients who were being followed-up by Movement Disorders Outpatient Clinic of Prof. Dr. Mazhar Osman Bakırköy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, 2nd Department of Neurology and not having history of cardiac disorder, diabetes, hypertension, electrolyte imbalance, chronic liver disease and renal failure and medication use affecting QT interval and 18 healthy people as the control group were included in the study. In ECG examination, due to negative effect of QT interval by previous RR interval, QT-c (corrected QT dispersion) which was calculated by Bazett formula (QT-c= QT/(RR)½) was used in assessments. QT, QT-c and RR assessments were done by auto-analyzing ECG device.
Statistical Analysis
SPSS (11.5 version) package software was used for biostatistical analyses. When study data were being evaluated, in addition to descriptive statistical methods (mean, standard deviation) Student's t-test was used to compare quantitative data and inter-group comparisons of parameters having normal distribution. Chi-square test was used to compare qualitative data. Significance level was taken as p<0.05. Spearman correlation test was used for correlation analysis (r value).
RESULTS
There were 12 women (60%) and 8 men (40%) at the patient group and 6 women (33.3%) and 12 men (66.7%) at the control group. Mean age was 69.8 (±8.57) at the patient group and 64.8 (±8.71) at the control group. Mean disease duration was 6.1 (±3.1) years. No significant correlation was found between disease duration and QT, QT-c and RR values (p>0.05) ( Table 1) . QT, QT-c and RR values were compared for gender at both groups and no significant difference was found (χ 2 =0.70, p=0.10). QT and QT-c mean values were assessed at both groups. Mean QT-c value of patients (423.75 msec.) was significantly higher (p<0.001) than the control group (404.16 msec.) and also mean QT value of patients (397.70 msec.) was significantly higher (p<0.001) than the control group (374.44 msec.). R-R interval was calculated at each group and no significant difference was found (p=0.12) ( Table 2 ). Patients were using combinations of L-Dopa, Dopa agonists, MAO-B inhibitors so their effects on QT interval could not be assessed.
DISCUSSION
QT interval of ECG represents total ventricular myocardial depolarization and repolarization duration (3, 4) . Prolongation of QT interval which is concomitant with ventricular arrhythmia has been related to unexpected cardiovascular deaths (1) . QT prolongation and sudden death have been reported due to autonomic dysfunction in patients with PD and multi-system atrophy (MSA) in the literature (1, (3) (4) (5) (6) . For this reason, QT interval is important for follow-up and treatment of these patients. QT-c and R-R interval assessments were performed in studies done with patients with PD and MSA and prolongation of QT-c interval was detected compared to control group but no significant difference was found at R-R interval and QT (7) . In PD, QT-c interval was compared between patients who are taking antiParkinsonian medications and unmedicated group: no significant difference was found. In our study, we also found a highly significant difference of mean QT-c in PD compared to healthy controls which is consistent with the literature. However, mean QT was also found significantly higher than healthy control group contrary to the literature (7) . No significant difference was found at R-R interval assessments at both groups, and this is also consistent with the literature. In another study, QT-c interval length was found to be correlated with disease duration (7) . No significant correlation was found in our study. No correlation was found between medications used in the treatment and QT-c interval in the same study (8, 9) . Effect of anti-Parkinsonian medications on QT-c interval could not be compared statistically due to similar combination of medications being used in our patient group.
Cardio-selective sympathetic denervation in PD can be explained by a number of characteristics. First, catecholaminergic cells in basal ganglia decrease proportionally by increasing severity of PD. Another characteristic is presence of Lewy bodies in cardiac plexus in PD (10, 11) . Oxidative or neurotoxic processes leading to cellular degeneration at central nervous system in PD may also lead to impairment of adrenergic tracts (12, 13) . Post-ganglionic sympathetic fibers are affected by this route. Rapid oxidative deamination of noradrenalin in cardiac sympathetic nerves has a role in cardio-selective denervation in PD (14) .
In conclusion, QT-c changes in PD have an important role in cardio-selective factors such as pathological changes in post-ganglionic sympathetic and intrinsic neurons. For this reason, assessment of QT-c in Parkinson patients with predominant autonomic symptoms may be important for risk of sudden death and when prolongation of QT-c interval was detected, follow-up of patients with cardiology department will be appropriate.
